DERMÁLNÍ NÁHRADY V REKONSTRUKČNÍ CHIRURGII: SOUČASNÝ STAV A PERSPEKTIVY

Stiahnuť PDF

Autori: M. Knoz ^1,2,3; J. Holoubek ^2,3; B. Lipový ^2,3; I. Suchánek ³; I. Kaloudová ³; T. Kempný ^2,3; Z. Dvořák ^1,2
Pôsobisko autorov: Department of Plastic and Aesthetic Surgery, St. Anne’s University Hospital Brno, Czech Republic ¹; Faculty of Medicine, Masaryk University Brno, Czech Republic ²; Department of Burns and Plastic Surgery, University Hospital Brno, Czech Republic ³
Vyšlo v časopise: ACTA CHIRURGIAE PLASTICAE, 62, 1-2, 2020, pp. 18-23

Zdroje

1. Bombaro KM., Engrav LH., Carrougher GJ., Wiechman SA., Faucher L., Costa BA, et al. What is the prevalence of hypertrophic scarring following burns? Burns. 2003, 29:299–302.

2. Šín P., Brychta P. Cutometrical measurement confirms the efficacy of the composite skin grafting using allogenic acellular dermis in burns, Acta chirurgiae plasticae. 2006, 48:59–64.

3. Nicoletti G., Tresoldi MM., Malovini A., Visaggio M., Faga A., Scevola S. Versatile use of dermal substitutes: A retrospective survey of 127 consecutive cases. Indian J Plast Surg. 2018, 51:46–53.

4. Sando IC., Chung KC. The Use of Dermal Skin Substitutes for the Treatment of the Burned Hand. Hand Clin. 2017, 33:269–76.

5) Van Der Veen VC., van der Wal MBA., van Leuwen MCE., Ulrich MMW., Middelkoop E. Biological background of dermal substitutes. Burns. 2010, 36:305–21.

6. Lucich EA., Rendon JL., Valerio IL. Advances in addressing full-thickness skin defects: a review of dermal and epidermal substitutes. Regen Med. 2018, 13:443–56.

7. Alisky JM. Xenografts are an achievable breakthrough. Med Hypotheses. 2004, 63:92–7.

8. Lucas D., Di Rocco D., Müller CT., Jurjus AR., Raffoul W., di Summa PG., Watfa W. Application of Dermal Skin Substitutes for Hand and Finger Palmar Soft Tissue Loss. Plast Reconstr Surg Glob Open. 2019, 7:2551.

9. Goodarzi P., Falahzadeh K., Nematizadeh M., Farazandeh P., Payab M., Larijani B., Tayanloo Beik A., Arjmand B. Tissue Engineered Skin Substitutes. Adv Exp Med Biol. 2018, 1107:143–88.

10. Shores JT., Gabriel A., Gupta S. Skin substitutes and alternatives: a review. Adv Skin Wound Care. 2007, 20:493–508.

11. Wainwright DJ. Use of an acellular allograft dermal matrix (AlloDerm) in the management of full-thicknessburns. Burns. 1995, 21:243–8.

12. Butler CE., Langstein HN., Kronowitz SJ. Pelvic, abdominal, and chest wall reconstruction with AlloDerm in patients at increased risk for mesh-related complications. Plast Reconstr Surg. 2005, 116:1263–75, discussion 1276–7.

13. Tobin HA., Karas ND. Lip augmentation using an AlloDerm graft. J Oral Maxillofac Surg. 1998, 56:722–7.

14. Gordley K., Cole P., Hicks J., et al. A comparative, long term assessment of soft tissue substitutes: AlloDerm, Enduragen, and Dermamatrix. J Plast Reconstr Aesthet Surg. 2009, 62 :849–50.

15. Cole PD., Stal D., Sharabi SE., et al. A comparative, longterm assessment of four soft tissue substitutes. Aesthet Surg J. 2011, 31:674–81.

16. Bano F., Barrington JW., Dyer R. Comparison between porcine dermal implant (Permacol) and silicone injection (Macroplastique) for urodynamic stress incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 2005, 16:147–50; discussion 150.

17. MacLeod TM., Cambrey A., Williams G, et al. Evaluation of Permacol as a cultured skin equivalent. Burns. 2008, 34:1169–75.

18. Badylak SF. The extracellular matrix as a biologic scaffold material. Biomaterials. 2007, 28:3587–93.

19. Hodde JP., Ernst DM., Hiles MC. An investigation of the long-term bioactivity of endogenous growth factor in OASIS Wound Matrix. J Wound Care. 2005, 14:23–5.

20. Mostow EN., Haraway GD., Dalsing M, et al; OASIS Venus Ulcer Study Group. Effectiveness of an extracellular matrix graft (OASIS Wound Matrix) in the treatment of chronic leg ulcers: a randomized clinical trial. J Vasc Surg. 2005, 41 :837–43.

21. Romanelli M., Dini V., Bertone M., et al. OASIS Wound Matrix versus Hyaloskin in the treatment of difficult-to-heal wounds of mixed arterial/venous aetiology. Int Wound J. 2007, 4:3–7.

22. Niezgoda JA., Van Gils CC., Frykberg RG., et al. Randomized clinical trial comparing OASIS Wound Matrix to Regranex Gel for diabetic ulcers. Adv Skin Wound Care. 2005, 18:258–66.

23. Bose B. Burn wound dressing with human amniotic membrane. Ann R Coll Surg Engl. 1979, 61:444–7.

24. Qader AR., Rasul FK. Evaluation of using amniotic membrane dressing in superficial burns. J Sulaimani Medical College. 2011, 1:1–11.

25. Vats A., Tolley NS., Polak JM., et al. Scaffolds and biomaterials for tissue engineering: a review of clinical applications. Clin Otolaryngol Allied Sci. 2003, 28:165–72.

26. Zhong SP., Zhang YZ., Lim CT. Tissue scaffolds for skin wound healing and dermal reconstruction. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2010, 2:510–25.

27. Wang Y., Kim HJ., Vunjak-Novakovic G., et al. Stem cell-based tissue engineering with silk biomaterials. Biomaterials. 2006, 27:6064–82.

28. Dai NT., Williamson MR., Khammo N., et al. Composite cell support membranes based on collagen and polycaprolactone for tissue engineering of skin. Biomaterials. 2004, 25:4263–71.

29. Bezwada RS., Jamiolkowski DD., Lee IY., et al. Monocryl suture, a new ultra-pliable absorbable monofilament suture. Biomaterials. 1995, 16:1141–48.

30. Brown RP. Knotting technique and suture materials. Br J Surg. 1992, 79:399–400.

31. Debels H., Hamdi M., Abberton K., Morrison W. Dermal matrices and bioengineered skin substitutes: a critical review of current options. Plast Reconstr Surg Glob Open. 2015, 3:284.

32. Burke JF., Yannas IV., Quinby WC. Jr, et al. Successful use of a physiologically acceptable artificial skin in the treatment of extensive burn injury. Ann Surg. 1981, 194:413–28.

33. Jones I., Currie L., Martin R. A guide to biological skin substitutes. Br J Plast Surg. 2002, 55:185–93.

34. Akguner M., Barutcu A., Yilmaz M., Karatas O., Vayvada H. Marjolin’s ulcer and chronic burn scarring. J Wound Care. 1998, 7:121–2.

35. Haslik W., Kamolz LP., Manna F., Hladik M., Rath T., Frey M. Management of full-thickness skin defects in the hand and wrist region: First long-term experiences with the dermal matrix Matriderm. J Plast Reconstr Aesthet Surg. 2010, 63:360–4.

36. Schneider J., Biedermann T., Widmer D., Montano I., Meuli M., Reichmann E., et al. MatriDerm^® versus Integra^®: A comparative experimental study. Burns. 2009, 35:51–7.

37. Inhoff O., Faulhaber J., Rothhaar B., Goerdt S., Koenen W. Analysis of treatment costs for complex scalp wounds. J Dtsch Dermatol Ges. 2010, 8:890–6.

38. Bell E., Ehrlich HP., Buttle DJ., et al. Living tissue formed in vitro and accepted as skin-equivalent tissue of full thickness. Science. 1981, 211:1052–4.

39. Hansbrough JF., Boyce ST., Cooper ML., et al. Burn wound closure with cultured autologous keratinocytes and fibroblasts attached to a collagen-glycosaminoglycan substrate. JAMA. 1989, 262:2125–30.

40. Hendrickx B., Vranckx JJ., Luttun A. Cell-based vascularization strategies for skin tissue engineering. Tissue Eng Part B Rev. 2011, 17:13–24.

41. Jones I., Currie L., Martin R. A guide to biological skin substitutes. Br J Plast Surg. 2002, 55:185–93.